162 related articles for article (PubMed ID: 38338673)
1. A Missense Variant in
Usategui-Martín R; Galindo-Cabello N; Pastor-Idoate S; Fernández-Gómez JM; Del Real Á; Ferreño D; Lapresa R; Martín-Rodriguez F; Riancho JA; Almeida Á; Pérez-Castrillón JL
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338673
[TBL] [Abstract][Full Text] [Related]
2. Neovascularization and functional recovery after intracerebral hemorrhage is conditioned by the Tp53 Arg72Pro single-nucleotide polymorphism.
Rodríguez C; Sobrino T; Agulla J; Bobo-Jiménez V; Ramos-Araque ME; Duarte JJ; Gómez-Sánchez JC; Bolaños JP; Castillo J; Almeida Á
Cell Death Differ; 2017 Jan; 24(1):144-154. PubMed ID: 27768124
[TBL] [Abstract][Full Text] [Related]
3. The Neuronal Ischemic Tolerance Is Conditioned by the Tp53 Arg72Pro Polymorphism.
Ramos-Araque ME; Rodriguez C; Vecino R; Cortijo Garcia E; de Lera Alfonso M; Sanchez Barba M; Colàs-Campàs L; Purroy F; Arenillas JF; Almeida A; Delgado-Esteban M
Transl Stroke Res; 2019 Apr; 10(2):204-215. PubMed ID: 29687302
[TBL] [Abstract][Full Text] [Related]
4. Frequency of TP53 mutations in relation to Arg72Pro genotypes in non small cell lung cancer.
Lind H; Ekstrøm PO; Ryberg D; Skaug V; Andreassen T; Stangeland L; Haugen A; Zienolddiny S
Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):2077-81. PubMed ID: 17932356
[TBL] [Abstract][Full Text] [Related]
5. Association between TP53 Arg72Pro polymorphism and thyroid carcinoma risk.
Wang F; Wang P; Wang B; Fu ZJ; Yuan Y; Yan SL; Zhao WJ; Wang YG
Tumour Biol; 2014 Mar; 35(3):2723-8. PubMed ID: 24375191
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of association between the TP53 Arg72Pro polymorphism and risk of endometriosis based on case-control studies.
Yan Y; Wu R; Li S; He J
Eur J Obstet Gynecol Reprod Biol; 2015 Jun; 189():1-7. PubMed ID: 25819169
[TBL] [Abstract][Full Text] [Related]
7. Association between TP53 Arg72Pro polymorphism and leukemia risk: a meta-analysis of 14 case-control studies.
Tian X; Dai S; Sun J; Jiang S; Jiang Y
Sci Rep; 2016 Apr; 6():24097. PubMed ID: 27053289
[TBL] [Abstract][Full Text] [Related]
8. Quantitative assessment of the association between TP53 Arg72Pro polymorphism and bladder cancer risk.
Liu ZH; Bao ED
Mol Biol Rep; 2013 Mar; 40(3):2389-95. PubMed ID: 23184052
[TBL] [Abstract][Full Text] [Related]
9. Increased risk of non-small cell lung cancer and frequency of somatic TP53 gene mutations in Pro72 carriers of TP53 Arg72Pro polymorphism.
Szymanowska A; Jassem E; Dziadziuszko R; Borg A; Limon J; Kobierska-Gulida G; Rzyman W; Jassem J
Lung Cancer; 2006 Apr; 52(1):9-14. PubMed ID: 16499995
[TBL] [Abstract][Full Text] [Related]
10. TP53 Arg72Pro and XPD Lys751Gln Gene Polymorphisms and Risk of Lung Cancer in Bangladeshi Patients.
Nairuz T; Rahman M; Bushra MU; Kabir Y
Asian Pac J Cancer Prev; 2020 Jul; 21(7):2091-2098. PubMed ID: 32711437
[TBL] [Abstract][Full Text] [Related]
11. Pro variant of TP53 Arg72Pro contributes to esophageal squamous cell carcinoma risk: evidence from a meta-analysis.
Wang B; Wang D; Zhang D; Li A; Liu D; Liu H; Jin H
Eur J Cancer Prev; 2010 Jul; 19(4):299-307. PubMed ID: 20389250
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of the TP53 Arg72Pro single-nucleotide polymorphism and susceptibility to medulloblastoma in a cohort of Brazilian patients.
Carvalho RM; Pinto GR; Yoshioka FK; Lima PD; Souza CR; Guimarães AC; Lamarão LM; Rey JA; Burbano RR
J Neurooncol; 2012 Oct; 110(1):49-57. PubMed ID: 22886512
[TBL] [Abstract][Full Text] [Related]
13. TP53 codon 72 polymorphism in susceptibility, overall survival, and adjuvant therapy response of gliomas.
Lima-Ramos V; Pacheco-Figueiredo L; Costa S; Pardal F; Silva A; Amorim J; Lopes JM; Reis RM
Cancer Genet Cytogenet; 2008 Jan; 180(1):14-9. PubMed ID: 18068527
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of TP53 Pro47Ser and Arg72Pro single nucleotide polymorphisms and the susceptibility to gliomas in individuals from Southeast Brazil.
Pinto GR; Yoshioka FK; Silva RL; Clara CA; Santos MJ; Almeida JR; Burbano RR; Rey JA; Casartelli C
Genet Mol Res; 2008 Feb; 7(1):207-16. PubMed ID: 18393224
[TBL] [Abstract][Full Text] [Related]
15. Quantitative assessment of the association between TP53 Arg72Pro polymorphism and risk of glioma.
Zhang F; Li D; Li Y; Li H; Sun J; Li X; Li X
Tumour Biol; 2014 Jan; 35(1):747-51. PubMed ID: 24046089
[TBL] [Abstract][Full Text] [Related]
16. Cigarette smoking, TP53 Arg72Pro, TP53BP1 Asp353Glu and the risk of lung cancer in a Japanese population.
Kiyohara C; Horiuchi T; Miyake Y; Takayama K; Nakanishi Y
Oncol Rep; 2010 May; 23(5):1361-8. PubMed ID: 20372852
[TBL] [Abstract][Full Text] [Related]
17. p.Arg72Pro polymorphism of P53 and breast cancer risk: a meta-analysis of case-control studies.
Diakite B; Kassogue Y; Dolo G; Wang J; Neuschler E; Kassogue O; Keita ML; Traore CB; Kamate B; Dembele E; Nadifi S; Murphy RL; Doumbia S; Hou L; Maiga M
BMC Med Genet; 2020 Oct; 21(1):206. PubMed ID: 33076844
[TBL] [Abstract][Full Text] [Related]
18. Lack of association of the TP53 Arg72Pro SNP and the MDM2 SNP309 with systemic lupus erythematosus in Caucasian, African American, and Asian children and adults.
Onel KB; Huo D; Hastings D; Fryer-Biggs J; Crow MK; Onel K
Lupus; 2009 Jan; 18(1):61-6. PubMed ID: 19074170
[TBL] [Abstract][Full Text] [Related]
19. TP53 Arg72Pro polymorphism is associated with esophageal cancer risk: a meta-analysis.
Jiang DK; Yao L; Wang WZ; Peng B; Ren WH; Yang XM; Yu L
World J Gastroenterol; 2011 Mar; 17(9):1227-33. PubMed ID: 21448430
[TBL] [Abstract][Full Text] [Related]
20. p53 codon 72 polymorphism is associated with susceptibility to hepatocellular carcinoma in the Turkish population: a case-control study.
Sümbül AT; Akkız H; Bayram S; Bekar A; Akgöllü E; Sandıkçı M
Mol Biol Rep; 2012 Feb; 39(2):1639-47. PubMed ID: 21607615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
